Ameritas Investment Partners’s Greenwich LifeSciences GLSI Stock Holding History

Ameritas Investment Partners’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.7K	Hold	585	–	–	﹤0.01%	2929
2026 Q1	$14.1K	Hold	585	–	–	﹤0.01%	2754
2025 Q4	$12.3K	Hold	585	–	–	﹤0.01%	2846
2025 Q3	$5.82K	Hold	585	–	–	﹤0.01%	3045
2025 Q2	$5.31K	Hold	585	–	–	﹤0.01%	3100
2025 Q1	$5.58K	Hold	585	–	–	﹤0.01%	2950
2024 Q4	$6.57K	Hold	585	–	–	﹤0.01%	2992
2024 Q3	$8.41K	Hold	585	–	–	﹤0.01%	2966
2024 Q2	$10.1K	Buy	+585	New	+$8.55K	﹤0.01%	2927
2022 Q2	–	Sell	-316	Closed	-$6K	–	3131
2022 Q1	$6K	Hold	316	–	–	﹤0.01%	2930
2021 Q4	$8K	Hold	316	–	–	﹤0.01%	2958
2021 Q3	$12K	Hold	316	–	–	﹤0.01%	2888
2021 Q2	$14K	Buy	+316	New	+$12K	﹤0.01%	2866

Other funds holding GLSI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ameritas Investment Partners's GLSI Position: Q2 2026 in Review

Ameritas Investment Partners held its Greenwich LifeSciences (GLSI) position steady in Q2 2026 at 585 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2929.

Ameritas Investment Partners first reported a position in GLSI in Q2 2021 and has held it in 13 quarters since. The position peaked at $14.1K in Q1 2026. 57 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

Ameritas Investment Partners held 585 shares of Greenwich LifeSciences worth $13.7K as of Q2 2026.
Ameritas Investment Partners left its Greenwich LifeSciences share count unchanged in Q2 2026.
Greenwich LifeSciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2929 holding.
Ameritas Investment Partners first reported a position in Greenwich LifeSciences in Q2 2021 and has held it in 13 quarters since.
Ameritas Investment Partners's Greenwich LifeSciences position peaked at $14.1K in Q1 2026.
57 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.